Aktiesnakken — Februar 2017
-
DARA POM DEX isn’t approved yet, which means that we’ll only see the sales generated by this combo in the JnJ quarterly update and not in the Symphony Health monthly update. Seen a substantial number of patients will be treated with this not yet approved combo it could be that the monthly Symphony Health number will be lower than expected and that we’ll only see the true impact with the quarterly JnJ numbers or the monthly data will already be good / fantastic and we’ll get a big surprise with t
-
with the quarterly JnJ numbers.
Interesting to keep in mind
-
wrong debat, my bad
-
På utallige opfordringer.
-
-
Helge, det kan sagtens være, at MobilePay er midlertidigt lukket ned grundet den pludselige stigning i transaktioner. Det kan have triggered systemerne, som følge deraf lukker ned. Så hvis det fortsætter med at drille burde du hurtigt kunne fikse det ved at ringe til MP
-
Jeg var i kontakt med serviceafdelingen med det samme, De kunne ikke forklare nedlukningen, men fik ordnet problemet i løbet af en lille halv time.
-
Se med i morgen.
Kl. 13-14 kommenterer jeg regnskab fra Fingerprint Cards på Børsen Play TV. Det samme gør jeg med Domenick Beskos fra Momentum Market i TV2 i Millionærklubben på TV2 News kl. 18,20. Her har vi også Novos regnskab på programmet.
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind